organ transplant immunosuppressant drugs market n.
Download
Skip this Video
Loading SlideShow in 5 Seconds..
Organ Transplant Immunosuppressant Drugs Market Production, Revenue and Capacity Forecast to 2022 PowerPoint Presentation
Download Presentation
Organ Transplant Immunosuppressant Drugs Market Production, Revenue and Capacity Forecast to 2022

Loading in 2 Seconds...

play fullscreen
1 / 5

Organ Transplant Immunosuppressant Drugs Market Production, Revenue and Capacity Forecast to 2022 - PowerPoint PPT Presentation


  • 3 Views
  • Uploaded on

Immunosuppressant’s are a cluster of drugs that are utilized to suppress the immune response through several biological mechanisms.

loader
I am the owner, or an agent authorized to act on behalf of the owner, of the copyrighted work described.
capcha
Download Presentation

PowerPoint Slideshow about 'Organ Transplant Immunosuppressant Drugs Market Production, Revenue and Capacity Forecast to 2022' - Mohankamble


An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript
organ transplant immunosuppressant drugs market

Organ Transplant Immunosuppressant Drugs Market

Production, Revenue and Capacity Forecast to 2022

The factors that propel the growth of the Organ Transplant and

Immunosuppressant Drug Market include rising frequency of chronic diseases,

expanding number of organ donor, effective method for treatment of end-

stage organ failure, high demand for organ transplant. This consequently gives

rise to a high demand for immunosuppressant drugs to avoid organ rejection

after transplantation.

In the recent years, organ transplantation has rapidly advanced as a therapeutic interpolation that is

lifesaving as well as greatly funds to a better quality of life to organ beneficiaries. The rapid

development has been made possible due to extreme growth in the immunosuppressive stock.

However, the side effects of these drugs can be severe, which is one the reasons that life expectancy

of patients still considerably falls short. Immunosuppressant’s are a cluster of drugs that are utilized

to suppress the immune response through several biological mechanisms. In case of organ

transplantation, immunosuppressants are basically utilized to inhibit the attack or recognition of the

imported organ via several immune responses. They should be used only under administration of

expertise.

Browse Full Research Report @

https://www.millioninsights.com/industry-reports/organ-transplant-immunosuppressant-drugs-market

at times there may be also side effects

At times there may be also side-effects accompanied by immunosuppressant drugs such as increased

proneness of infection, overdue wound healing, dyspepsia, etc. The factors that propel the growth of

the Organ Transplant and Immunosuppressant Drug Market include rising frequency of chronic

diseases, expanding number of organ donor, effective method for treatment of end-stage organ

failure, high demand for organ transplant. This consequently gives rise to a high demand for

immunosuppressant drugs to avoid organ rejection after transplantation. On the other hand, there

are factors that hinder the growth of the market like expenditure of organ transplantation, post

transplantation problems, and risk of infection. The Organ Transplant and Immunosuppressant Drug

Market is categorized on the basis of drugs, transplant areas, and geography.

On the basis of drugs, the Organ Transplant and Immunosuppressant Drug Market is categorized as

pyrimidine synthesis (DHODH) inhibitors (leflunomide, azathioprine), depleting antibodies (horse or

rabbit antithymocyte globulin, muromonab-CD3, alemtuzumab, rituximab), non-depleting antibodies

and fusion proteins (daclizumab, basiliximab, belatacept), purine synthesis (IMDH) inhibitors

(mycophenolatemofetil, enteric-coated mycophenolic acid (EC-MFS), mizoribine (MZR)), protease

inhibitor (bortezomib), C5 inhibitor (eculizumab), calcineurin inhibitors (cyclosporine, tacrolimus),

and mTOR inhibitors (sirolimus, everolimus). Based on transplant areas, the Organ Transplant and

Immunosuppressant Drug Market is categorized as heart, kidney, lung, liver, and pancreas. In 2014,

the demand was the highest for immunosuppressant drugs utilized through kidney transplant. During

the forecast period kidney transplant sector is anticipated to account for the largest the market due

to cost effectiveness than persistent period of dialysis, rise of kidney transplants, and so on.

Request Sample Copy of this Market Research @

https://www.millioninsights.com/industry-reports/organ-transplant-immunosuppressant-drugs-market/request-sample

Based on geography, the Organ Transplant and Immunosuppressant Drug Market is categorized as

North America, Europe, Asia Pacific, and Rest of the World. In 2014, North America dominated the

global Organ Transplant Immunosuppressant Drug Market owing to the greater number of organ

transplants carried out within as well as sophisticated medical facilities such as technology

development, immunosuppressant drug discovery, surgical techniques and healthcare structure.

North America is anticipated to be the fastest growing region followed by Europe. Some of the

prominent players that fuel the growth of the Organ Transplant Immunosuppressant Drug Market

include Astellas Pharma, Accord Healthcare Ltd., Inc., Novartis AG, Pfizer, Inc., Sanofi, Genzyme

corporation watson pharmaceuticals inc mylan

Corporation, Watson Pharmaceuticals Inc.,Mylan Laboratories, Inc., GlaxoSmithKline plc, and

Hoffman La Roche.

Market Segment:

This report studies Organ Transplant Immunosuppressant Drugs in Global market, especially in

North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in

global market, with capacity, production, price, revenue and market share for each manufacturer,

covering

• Huadong Pharmaceutical

• North China Pharmaceutical HuaSheng Co.

• Sinopharm Chuan Kang Pharmaceutical

• HISUN

• SL Pharm

• Nanjing HICIN

• Hongsheng

• Cinkate

• Wansui

• Huitian

• Roche

• AstellasIreland Co.,Ltd

• Novartis

• Catalent Pharma

• Cilag

• Genzyme

• Changzhou Pharm

• Livzon Pharmaceutical Group Inc.

See More Reports of this Category by Million Insights @

https://www.millioninsights.com/industry/pharmaceuticals

Market Segment by Regions, this report splits Global into several key Regions, with production,

consumption, revenue, market share and growth rate of Organ Transplant Immunosuppressant

Drugs in these regions, from 2012 to 2022 (forecast), like

• North America

europe china japan southeast asia india

• Europe

• China

• Japan

• Southeast Asia

• India

Split by product type, with production, revenue, price, market share and growth rate of each type,

can be divided into

• Chemical Composition

• Fungal Product

• Biologics

Read Detail Market Research Report @

https://www.millioninsights.com/industry-reports/organ-transplant-immunosuppressant-drugs-market

Split by application, this report focuses on consumption, market share and growth rate of Organ

Transplant Immunosuppressant Drugs in each application, can be divided into

• Liver Transplant

• Kidney Transplant

get in touch

Get in touch

At Million Insights, we work with the aim to reach the highest levels of customer satisfaction.

Our representatives strive to understand diverse client requirements and cater to the same with the

most innovative and functional solutions.

Contact Person:

Ryan Manuel

Research Support Specialist, USA

Email: ryan@millioninsights.com

Global Headquarters

Asia Pacific

Million Insights

Million Insights

Felton Office Plaza 6265 Highway 9

Felton, California 95018, United States

Office No. 302, 3rd Floor, Manikchand

Galleria, Model Colony, Shivaji Nagar,

Pune, MH, 411016 India

Phone: 1-408-610-2300

Email: sales@millioninsights.com

Phone: 91-20-65300184

Email: sales@millioninsights.com

Visit Our Blog: www.millioninsights.blogspot.com